98%
921
2 minutes
20
The efficient recognition of circulating tumor cells (CTCs) with an aptamer probe confers numerous benefits; however, the stability and binding affinity of aptamers are significantly hampered in real biological sample matrices. Inspired by the efficient preying mechanism by multiplex tubing feet and endoskeletons of sea urchins, we engineered a superefficient biomimetic single-CTC recognition platform by conjugating dual-multivalent-aptamers (DMAs) Sgc8 and SYL3C onto AuNPs to form a sea urchin-like nanoprobe (sea urchin-DMA-AuNPs). Aptamers Sgc8 and SYL3C selectively bind with the biomarker proteins PTK7 and EpCAM expressed on the surface of CTCs. CTCs were captured with 100% efficiency, followed by sorting on a specially designed multifunctional microfluidic configuration, integrating a single-CTC separation unit and a hydrodynamic filtrating purification unit. After sorting, background-free analysis of biomarker proteins in single CTCs was undertaken with inductively coupled plasma mass spectrometry by measuring the amount of Au isotope in sea urchin-DMA-AuNPs. With respect to a single-aptamer nanoprobe/-interface, the dual-aptamer nanoprobe improves the binding efficiency by more than 200% ( < 0.35 nM). The microchip facilitates the recognition of single CTCs with a sorting separation rate of 93.6% at a flow rate of 60 μL min, and it exhibits 73.8 ± 5.0% measurement efficiency for single CTCs. The present strategy ensures the manipulation and detection of a single CTC in 100 μL of whole blood within 1 h.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acsami.1c11953 | DOI Listing |
Small
August 2025
Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Med
Hepatocellular carcinoma (HCC) represents the predominant malignant hepatic neoplasm globally and constitutes a principal contributor to cancer-associated mortality. Contemporary diagnostic methodologies exhibit limited sensitivity for early-stage detection, while the disease's substantial metastatic propensity and recurrence rates significantly compromise survival outcomes. Circulating tumor cells (CTCs), detectable throughout disease progression and harboring crucial pathological signatures, present compelling potential as liquid biopsy biomarkers for early-stage detection and prognostic assessment.
View Article and Find Full Text PDFSmall
August 2025
Laboratory for Biomedical Photonics, Institute of Laser Engineering, School of Physics and Optoelectronic Engineering, Beijing University of Technology, Beijing, 100124, China.
Metastatic spread in aggressive cancers is often initiated by circulating tumor cells (CTCs) before primary tumor detection. Current CTC analysis faces fundamental limitations due to extreme cell scarcity (≈10 cells mL blood) and reliance on large sample volumes (>7.5 mL).
View Article and Find Full Text PDFCancers (Basel)
August 2025
Medical Oncology, Ingham Institute for Applied Medical Research, Liverpool, NSW 2170, Australia.
: Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumour, associated with poor survival outcomes and significant clinical challenges. Conventional diagnostic methods, including MRI, CT, and histopathological analysis of tissue biopsies, are limited by their inability to reliably distinguish treatment effects from true tumour progression, often resulting in misdiagnosis and delayed intervention. Repeated tissue biopsies are also invasive and unsuitable for longitudinal monitoring.
View Article and Find Full Text PDFJ Cancer Res Clin Oncol
August 2025
Department of Immunology and Serology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 40-055, Katowice, Poland.
Breast cancer is a heterogeneous disease, which is still a challenge for modern cancer diagnostics. Despite significant progress in diagnosis, monitoring and treatment of breast cancer, it remains the leading cause of cancer-related death in women. Effective screening methods, which enable early diagnosis of the disease and rapid personalised treatment are crucial to improving survival of women with breast cancer.
View Article and Find Full Text PDFBiol Proced Online
August 2025
Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China.
Background: Circulating tumor cells (CTCs) serve as the “seeds” of tumor metastasis, and the clustering of CTCs is critically associated with tumor metastasis and the mortality of lung cancer patients. Inhibiting the survival of CTC clusters represents a pivotal strategy for anti-lung cancer metastasis therapy. This study is designed to explore the impact and underlying mechanism of lung cancer CTC clusters in mediating resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), thereby offering novel insights into anti-lung cancer metastasis treatment.
View Article and Find Full Text PDF